Metabolically Armed CD19 CAR-T cells Clinical Trials
4 recruitingDrug
Early Phase 14
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
Systemic Lupus Erythematosus
Zhejiang University36 enrolled1 locationNCT06711146
Recruiting
Early Phase 1
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research
He Huang18 enrolled1 locationNCT06120166
Recruiting
Early Phase 1
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research
Non-hodgkin Lymphoma,B Cell
Zhejiang University36 enrolled1 locationNCT06716164
Recruiting
Early Phase 1
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
Acute Lymphoblastic Leukemia
The Children's Hospital of Zhejiang University School of Medicine36 enrolled1 locationNCT06393335